222 - How ICH Guidelines Are Organized: Understanding the Q, S, E, and M Series

Let's Combinate · 14 Jan 2026 · 12m

What this episode covers

Subhi Saadeh, founder of Let's Combinate BioWorks and host of the Let's Combinate podcast, provides a high-level orientation to the International Council for Harmonisation (ICH) guidelines, explaining their organization into Quality (Q), Safety (S), Efficacy (E), and Multidisciplinary (M) families. She emphasizes that while ICH guidelines are not regulations, they form the practical backbone of regulatory expectations for drug and drug-device combination products, particularly regarding stability, analytical validation, and quality systems. The episode details the specific scope of the 14 active Quality guidelines (Q1–Q14) and briefly outlines the roles of the S, E, and M series in the broader product lifecycle.

Most relevant to

established companies

Topics

Mentioned

Companies
International Council for Harmonisation, FDA, Let's Combinate BioWorks, Combination Products Coalition, AAMI
Also
ASTM Committee E55, ICH Q1, ICH Q2, ICH Q3, ICH Q4, ICH Q5, ICH Q6, ICH Q7, ICH Q8, ICH Q9, ICH Q10, ICH Q11, ICH Q12, ICH Q13, ICH Q14

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 38m

    #380: Navigating the Complex World of Combination Products with Subhi Saadeh

    Subhi Saadeh, host of the Combinate Podcast and expert in combination products, discusses the regulatory complexities of integrating drugs, devices, and biologics, including the differences between US FDA and EU regulatory pathways. He explains the definitions of single entity, co-packaged, and cross-labeled products, and addresses common misconceptions about the differences between drug and device quality systems. Saadeh also shares his journey of starting the podcast to maintain consistent learning and production, highlighting the importance of lifelong learning and leveraging coaching to balance technical and business aspects of the MedTech industry.

  • Global Medical Device Podcast · 42m

    #323 The Combination Products Handbook

    Susan Neadle, principal consultant and president of Combination Products Consulting Services, discusses her peer-reviewed book, The Combination Products Handbook: A Practical Guide, published by CRC Press. Neadle explains how she collaborated with FDA officials, including John Barwiener, and industry experts from companies like Johnson & Johnson, Novartis, and Pfizer to create a consolidated resource for the complex niche of combination products. The episode details the book's structure, covering regulatory strategies, CGMPs, risk management, and human factors, while highlighting the challenges of harmonizing terminology between pharmaceutical and medical device sectors. Neadle emphasizes the importance of holistic thinking and integrated development to ensure patient safety and regulatory compliance across global jurisdictions.

  • Global Medical Device Podcast · 35m

    #467: Combination Product Compliance: PMOA, 21 CFR Part 4 & QMS Alignment

    Jim Fentress, Director of Regulatory Affairs at Galero (a Santa Group company), explains the regulatory complexities of combination products, focusing on how the Primary Mode of Action (PMOA) dictates FDA oversight. He details the challenges pharmaceutical companies face when integrating device Quality Management Systems (QMSR/ISO 13485) into their existing CGMP frameworks under 21 CFR Part 4. The discussion covers specific friction points like risk management alignment (AAMI TIR105 vs. ICH Q9), labeling classifications, and the critical need for transparent change control protocols between device manufacturers and pharma partners.

  • Global Medical Device Podcast · 37m

    #390: Building a Non-BS QMS: 4 Core Principles for MedTech Success with Ashkon Rasooli

    Ashkon Rasooli, a quality and regulatory expert, joins host Etienne Nichols to outline four core principles for building an effective, non-burdensome Quality Management System (QMS) for medical device companies. Rasooli argues for 'Quality over Proceduralism,' 'Culture over Mandate,' 'Redundancy over Duplication,' and 'Conciseness over Verbosity' to ensure the QMS serves the business rather than just acting as a compliance checkbox. He advises new founders to engage quality and regulatory advisors early in the design phase to optimize architecture and avoid costly retrospective documentation. The discussion also covers the strategic decision of whether to treat quality as a minimum regulatory hurdle or a key business differentiator.

  • Global Medical Device Podcast · 58m

    #404: MedTech 101: What You Need to Know About the Medical Device Industry

    Etienne Nichols hosts Sara Adams and Chris Rush from Greenlight Guru for a foundational overview of the medical device industry. They define medical devices by intended use and labeling, distinguishing roles for Quality, Regulatory, Clinical, and R&D teams. The trio explains FDA classifications (Class I, II, III), regulatory pathways like 510(k) and PMA, and key standards including ISO 13485 and ISO 14971. They emphasize the importance of design controls, risk management, and reading regulations to navigate compliance and market access.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.